Genetic Signatures Ltd  ASX:GSS

Company

First Coverage

Logo
Genetic Signatures Ltd ASX:GSS

$ 0.52

04/09/2018

Report Date Price
Growth Portfolio 04/09/2018 $0.52

Overview

Genetic Signatures Ltd is a specialist molecular diagnostics (MDx) company focused on the development and commercialisation of its proprietary platform technology, 3base™.

Genetic Signatures has released a suite of real-time PCR based products for the routine detection of infectious diseases under the EasyScreen™ brand . This proprietary MDx technology provides hospitals and pathology laboratories with the ability to screen for a wide array of infectious pathogens with a high degree of specificity in a rapid throughput (time to result) environment.

The Genetic Signatures Ltd executive management team combines the scientific skills of the technology developers with the business acumen of industry veterans experienced in critical expansion markets.